Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg given for 24 days compared to a 21-day regimen.

被引：0

|

作者：

Ellman, H

Archer, DF

机构：

[1] CONRAD Clin Res Ctr, Norfolk, VA USA

[2] Warner Chilcott, Rockaway, NJ USA

来源：

FERTILITY AND STERILITY | 2005年 / 84卷

关键词：

D O I：

10.1016/j.fertnstert.2005.07.420

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

收藏

页码：S169 / S170

页数：2

相关论文

共 36 条

[31] Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles
Rabe, Thomas
Hartschuh, Elena
Wahlstrom, Torsten
Hoeschen, Kornelia
Koenig, Simone
CONTRACEPTION, 2010, 82 (04) : 358 - 365
[32] Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive (vol 80, pg 445, 2009)
Anttila, Leena
Kunz, Michael
Mar, Joachim
CONTRACEPTION, 2010, 81 (04) : 362 - 362
[33] Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis of four open-label studies
Anttila, Leena
Bachmann, Gloria
Hernadi, Laszlo
Kunz, Michael
Marr, Joachim
Klipping, Christine
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 155 (02) : 180 - 182
[34] Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 mu g/drospirenone 3 mg (24/4 regimen) in three indications in the People's Republic of China: a comparison with international studies
Marr, Joachim
Huang, Zirong
Wang, Baoxi
Zhang, Hongyan
Roth, Katrin
OPEN ACCESS JOURNAL OF CONTRACEPTION, 2015, 6 : 95 - 104
[35] The effect of 20 mu g ethinyl estradiol 1 mg norethindrone acetate (Minestrin(TM)), a low-dose oral contraceptive, on vaginal bleeding patterns, hot flashes, and quality of life in symptomatic perimenopausal women
Casper, RF
Dodin, S
Reid, RL
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 1997, 4 (03): : 139 - 147
[36] Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial
Koltun, William
Lucky, Anne W.
Thiboutot, Diane
Niknian, Minoo
Sampson-Landers, Carole
Korner, Paul
Marr, Joachim
CONTRACEPTION, 2008, 77 (04) : 249 - 256

← 1 2 3 4 →